Chad M Robins, CEO and Chairman at Adaptive Biotechnologies, sold ADPT on Aug 18, 2026
Data as of Oct 16
- Traded
- Aug 18, 2026
- Disclosed
- Aug 19, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ADPT since disclosure
−5.8%
after the sale
Similar stocks (XLV) since disclosure
+0.6%
XLV — its sector index fund
Change in closing price from Aug 19, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLChad M Robins CEO and ChairmanADPT Adaptive Biotechnologies Corp$6.8Mdisclosed Aug 19 · filed 1 day after the trade
- ▼ SELLChad M Robins CEO and ChairmanADPT Adaptive Biotechnologies Corp$8Mdisclosed Aug 19 · filed 2 days after the trade
- ▼ SELLChad M Robins CEO and ChairmanADPT Adaptive Biotechnologies Corp$64.6Kdisclosed Aug 19 · filed 2 days after the trade